Rakovina Therapeutics Inc.
RKVTF
$0.13
-$0.01-7.43%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 877.10K | 853.40K | 464.50K | 197.20K | 201.80K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.04M | 1.47M | 996.40K | 694.50K | 552.50K |
| Operating Income | -2.04M | -1.47M | -996.40K | -694.50K | -552.50K |
| Income Before Tax | -2.11M | -1.52M | -1.06M | -744.70K | -599.80K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.11M | -1.52M | -1.06M | -744.70K | -599.80K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.11M | -1.52M | -1.06M | -744.70K | -599.80K |
| EBIT | -2.04M | -1.47M | -996.40K | -694.50K | -552.50K |
| EBITDA | -1.95M | -1.38M | -899.90K | -595.40K | -454.80K |
| EPS Basic | -0.13 | -0.11 | -0.11 | -0.08 | -0.08 |
| Normalized Basic EPS | -0.08 | -0.07 | -0.07 | -0.05 | -0.05 |
| EPS Diluted | -0.13 | -0.14 | -0.13 | -0.08 | -0.09 |
| Normalized Diluted EPS | -0.08 | -0.07 | -0.07 | -0.05 | -0.05 |
| Average Basic Shares Outstanding | 15.91M | 14.08M | 10.02M | 8.97M | 7.07M |
| Average Diluted Shares Outstanding | 15.91M | 14.08M | 10.02M | 8.97M | 7.07M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |